Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Beta Innovation
Hong Kong, Hong Kongpmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
New Beta Innovation is focused on discovering and developing advanced hemoglobin-based therapeutics for use in oncology, neurology, and ischemic/hypoxic conditions. The company has established research collaborations with top universities globally but has not publicly disclosed specific clinical results or late-stage programs.
- Therapeutic areas
- CardiovascularNeurologyOncology
- Modalities
- Hemoglobin-based therapeuticsBiologic
- Industry
- Biotech
02
Partnerships
Ongoing research collaborations with top universities globally
Beyond the preview
Go deeper on New Beta Innovation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on New Beta Innovation.